Advertisement

Topics

NovImmune Company Profile

21:17 EST 19th November 2017 | BioPortfolio

NovImmune SA ('NovImmune') is a drug discovery and development company with a focus on therapeutic mAbs for inflammatory diseases and immune-related disorders.


News Articles [17 Associated News Articles listed on BioPortfolio]

Shire gets preclinical antibody candidate from Novimmune

Novimmune SA licensed Shire PLC exclusive global rights to develop and commercialize a bi-specific antibody for hemophilia A.

Shire Takes Novimmune’s Blood Therapy Rights

Shire has obtained exclusive worldwide rights from Novimmune for a bi-specific antibody that is currently in pre-clinical development for treating patients with the blood disorders hemophilia A and he...

FDA grants rare paediatric disease designation for Novimmune’s HLH emapalumab treatment

Swiss biopharmaceutical company Novimmune has received rare paediatric disease designation for its lead drug emapalumab from the US Food and Drug Administration (FDA) to treat patients with primary ha...

Shire Enters Bispecific Hemophilia Research and Development Deal with Novimmune

Lexington, MA – July 18, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG), the biotech leader in Rare Diseases; and Novimmune S.A., a privately-held Swiss biopharmaceutical company focused on the discov...

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

Shire has bought exclusive worldwide rights to develop and commercialize a bispecific antibody from Novimmune that could improve the treatment of hemophilia A.  Novimmune is a biotech from Geneva tha...

Novimmune partners with LegoChem Biosciences

Shire licensed bispecific antibody from Novimmune

Shire licenses Novimmune's hemophilia candidate

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

NovImmune

NovImmune SA ('NovImmune') is a drug discovery and development company with a focus on therapeutic mAbs for inflammatory diseases and immune-related disorders.

NovImmune SA

NovImmune SA (‘NovImmune’) is a drug discovery and development company with a focus on therapeutic mAbs for inflammatory diseases and immune-related disorders. NovImmune...

More Information about "NovImmune" on BioPortfolio

We have published hundreds of NovImmune news stories on BioPortfolio along with dozens of NovImmune Clinical Trials and PubMed Articles about NovImmune for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NovImmune Companies in our database. You can also find out about relevant NovImmune Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record